About
Piomic Medical is a Swiss MedTech company based in Zurich, founded in 2016. The company specializes in innovative wound care solutions, developed by a multidisciplinary team of biologists, engineers, designers, and entrepreneurs. Their primary product is the COMS® One Therapy System, a CE-marked medical device that utilizes Concurrent Optical and Magnetic Stimulation (COMS®) technology to enhance the healing of chronic wounds. This non-invasive therapy is designed for home care use, significantly improving healing rates and making it accessible for patients and healthcare systems. The COMS® therapy addresses the growing challenge of chronic wounds, which are prevalent due to aging populations and conditions like diabetes. By promoting faster wound closure, Piomic Medical aims to alleviate the financial burden on healthcare systems, which can reach up to USD 100 billion annually for chronic wound treatment. The company has received recognition for its innovation, winning the Most Innovative Product Award at the European Pressure Ulcer Advisory Panel (EPUAP) 2024. Piomic Medical continues to engage in research and development to expand its applications in wound care.
Technologies
Keywords
Company Information
-
Employees 15
-
Founded 2016
-
Annual Revenue $1600000
-
Total Funding $7830825
Location
6 Reitergasse, Zurich, Zurich, Switzerland, 8004